- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Bortezomib (drug)
Total 255389 results
-
Janssen Research & Development, LLCActive, not recruiting
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaAustralia, Japan, Spain, Germany, Poland, Belgium, Israel, Italy, Russian Federation, Canada, New Zealand, Korea, Republic of, China, Brazil, Czechia, United States, Netherlands, United Kingdom, Greece, France
-
Karyopharm Therapeutics IncActive, not recruitingMultiple MyelomaUnited States, United Kingdom, Australia, Israel, Canada, Belgium, Austria, Czechia, Serbia, India, France, Italy, Russian Federation, Bulgaria, Germany, Greece, Hungary, Poland, Romania, Spain, Ukraine
-
Peking Union Medical College HospitalXian-Janssen Pharmaceutical Ltd.Active, not recruitingAmyloidosis; SystemicChina
-
Joaquín Martínez López, MD, PhDHospital Infantil Universitario Niño Jesús, Madrid, SpainCompleted
-
Peking Union Medical College HospitalRecruitingIdiopathic Multicentric Castleman's DiseaseChina
-
M.D. Anderson Cancer CenterCompletedLymphoma | Solid Tumors | Myeloma | Advanced MalignancyUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.; Millennium Pharmaceuticals, Inc.Withdrawn
-
PharmaMarTerminated
-
University of Michigan Rogel Cancer CenterCompletedMultiple MyelomaUnited States
-
Sherif Farag, MB, BSHoosier Cancer Research Network; Cephalon, Inc.TerminatedBendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple MyelomaMultiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedHIV Infection | Recurrent Kaposi Sarcoma | AIDS-Related Kaposi SarcomaUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Breast Cancer | Ovarian Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
PETHEMA FoundationRecruitingRefractory Multiple MyelomaSpain
-
AbbVieActive, not recruitingMultiple MyelomaUnited States, France, Germany, Italy, Japan, Spain
-
Singapore General HospitalJanssen, LP; International Myeloma FoundationActive, not recruitingMultiple Myeloma | MyelomaSingapore
-
Assistance Publique - Hôpitaux de ParisFondation CentaureCompletedChronic Antibody-mediated Transplant RejectionFrance
-
H. Lee Moffitt Cancer Center and Research InstituteMillennium Pharmaceuticals, Inc.CompletedMultiple Myeloma | Plasma Cell LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma and other conditionsUnited States
-
Washington University School of MedicineSanofiTerminatedMultiple MyelomaUnited States
-
Eli Lilly and CompanyCompletedMultiple MyelomaMexico, United States, Germany, Italy, France, Poland, Taiwan, Spain, Turkey, United Kingdom, Korea, Republic of, Greece, Canada, Brazil, Netherlands
-
University of FloridaNovartis PharmaceuticalsWithdrawn
-
Iran Hepatitis NetworkBaqiyatallah Research Center for Gastroenterology and Liver DiseasesUnknown
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Recurrent Disease | Recurrent Adult Acute Lymphoblastic Leukemia | Adult Acute Monoblastic Leukemia | Adult Acute Monocytic Leukemia | Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 | Adult Acute Myeloid... and other conditionsUnited States
-
Northwestern UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedSystemic Sclerosis | Lung Diseases, Interstitial | SclerodermaUnited States
-
Joseph TuscanoMillennium Pharmaceuticals, Inc.CompletedAcute Myelogenous LeukemiaUnited States
-
The First Affiliated Hospital of Soochow UniversityNot yet recruitingMultiple Myeloma | Newly Diagnosed | MRD | High Risk
-
Grupo de Estudos Multicentricos em Onco-HematologiaCompletedMultiple Myeloma | Effects of Chemotherapy
-
National Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States, South Africa
-
AmgenCompletedMultiple MyelomaKorea, Republic of, Spain, Taiwan, Canada, Australia, Israel, Italy, United States, Singapore, New Zealand, Japan, Thailand, Brazil, United Kingdom, Hungary, Czechia, Romania, Slovakia, France, Germany, Russian Federation, Bulgaria, Belgiu... and more
-
Imperial College LondonAstraZeneca; Cancer Research UKCompleted
-
University College, LondonCompletedWaldenstrom's MacroglobulinaemiaUnited Kingdom
-
Janssen Research & Development, LLCCompleted
-
PETHEMA FoundationJanssen-Cilag Ltd.; Mundipharma Pharmaceuticals B.V.Completed
-
National Cancer Institute (NCI)CompletedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); The Emmes Company, LLCCompleted
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
H. Lee Moffitt Cancer Center and Research InstituteMillennium Pharmaceuticals, Inc.; Ortho Biotech, Inc.CompletedMultiple MyelomaUnited States
-
Jin Lu, MDRecruitingAL Amyloidosis | Amyloidosis; SystemicChina
-
AB ScienceTerminatedMultiple MyelomaUnited States, France
-
Washington University School of MedicineMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Nordic Myeloma Study GroupCompletedMultiple MyelomaDenmark, Sweden, Norway
-
Massachusetts General HospitalMillennium Pharmaceuticals, Inc.Completed
-
Pharmacyclics Switzerland GmbHJanssen Research & Development, LLCCompletedMultiple MyelomaSpain, Germany, Turkey, Greece, Italy, Czechia
-
SCRI Development Innovations, LLCMillennium Pharmaceuticals, Inc.; CephalonCompleted
-
Dayanand Medical College and HospitalCompleted
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLCWithdrawnStudy of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple MyelomaMultiple MyelomaUnited States